Market Closed -
Nyse
04:00:01 2024-05-08 pm EDT
|
5-day change
|
1st Jan Change
|
116.7
USD
|
+0.40%
|
|
+3.91%
|
+12.52%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
37,683
|
30,869
|
40,915
|
36,601
|
37,470
|
41,901
|
-
|
-
|
Enterprise Value (EV)
1 |
51,636
|
44,709
|
55,446
|
48,505
|
46,453
|
53,272
|
53,272
|
53,347
|
P/E ratio
|
9.27
x
|
-78.1
x
|
5.55
x
|
-25.3
x
|
15.4
x
|
9.3
x
|
8.61
x
|
7.7
x
|
Yield
|
4.27%
|
5.64%
|
4.25%
|
4.83%
|
4.82%
|
4.44%
|
4.52%
|
4.57%
|
Capitalization / Revenue
|
0.65
x
|
0.57
x
|
0.68
x
|
0.61
x
|
0.74
x
|
0.69
x
|
0.72
x
|
0.68
x
|
EV / Revenue
|
0.89
x
|
0.83
x
|
0.93
x
|
0.81
x
|
0.91
x
|
0.87
x
|
0.91
x
|
0.87
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
5.65
x
|
-
|
-
|
17.8
x
|
-
|
-
|
FCF Yield
|
-
|
-
|
17.7%
|
-
|
-
|
5.63%
|
-
|
-
|
Price to Book
|
0.6
x
|
0.47
x
|
0.67
x
|
2.27
x
|
1.35
x
|
1.43
x
|
1.31
x
|
1.18
x
|
Nbr of stocks (in thousands)
|
402,000
|
395,400
|
378,000
|
368,000
|
361,300
|
359,076
|
-
|
-
|
Reference price
2 |
93.74
|
78.07
|
108.2
|
99.46
|
103.7
|
116.7
|
116.7
|
116.7
|
Announcement Date
|
2/4/20
|
2/4/21
|
2/3/22
|
2/7/23
|
2/6/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
58,132
|
54,149
|
59,781
|
60,050
|
50,894
|
61,095
|
58,237
|
61,324
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
7,638
|
6,714
|
8,775
|
6,212
|
7,282
|
8,392
|
8,923
|
-
|
Operating Margin
|
13.14%
|
12.4%
|
14.68%
|
10.34%
|
14.31%
|
13.74%
|
15.32%
|
-
|
Earnings before Tax (EBT)
1 |
5,085
|
-323
|
9,381
|
-1,776
|
3,072
|
6,047
|
6,388
|
6,629
|
Net income
1 |
4,186
|
-374
|
7,724
|
-1,438
|
2,488
|
4,538
|
4,905
|
5,470
|
Net margin
|
7.2%
|
-0.69%
|
12.92%
|
-2.39%
|
4.89%
|
7.43%
|
8.42%
|
8.92%
|
EPS
2 |
10.11
|
-1.000
|
19.51
|
-3.930
|
6.740
|
12.55
|
13.56
|
15.15
|
Free Cash Flow
1 |
-
|
-
|
9,812
|
-
|
-
|
3,000
|
-
|
-
|
FCF margin
|
-
|
-
|
16.41%
|
-
|
-
|
4.91%
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
127.03%
|
-
|
-
|
66.11%
|
-
|
-
|
Dividend per Share
2 |
4.000
|
4.400
|
4.600
|
4.800
|
5.000
|
5.180
|
5.279
|
5.328
|
Announcement Date
|
2/4/20
|
2/4/21
|
2/3/22
|
2/7/23
|
2/6/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
13,744
|
13,657
|
13,774
|
21,611
|
11,008
|
15,104
|
12,644
|
12,206
|
13,020
|
21,699
|
14,223
|
13,723
|
13,864
|
14,011
|
13,547
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
1,947
|
1,930
|
1,273
|
1,433
|
1,576
|
1,707
|
1,853
|
2,023
|
-
|
1,998
|
2,111
|
2,159
|
2,109
|
-
|
-
|
Operating Margin
|
14.17%
|
14.13%
|
9.24%
|
6.63%
|
14.32%
|
11.3%
|
14.66%
|
16.57%
|
-
|
9.21%
|
14.84%
|
15.73%
|
15.21%
|
-
|
-
|
Earnings before Tax (EBT)
1 |
1,388
|
-115
|
-511
|
-437
|
-713
|
1,847
|
-
|
-1,058
|
-
|
-
|
1,627
|
1,667
|
1,536
|
-
|
-
|
Net income
1 |
1,208
|
-31
|
-565
|
-284
|
-558
|
1,462
|
511
|
-802
|
1,317
|
1,138
|
1,170
|
1,213
|
1,098
|
1,228
|
1,294
|
Net margin
|
8.79%
|
-0.23%
|
-4.1%
|
-1.31%
|
-5.07%
|
9.68%
|
4.04%
|
-6.57%
|
10.12%
|
5.24%
|
8.22%
|
8.84%
|
7.92%
|
8.77%
|
9.56%
|
EPS
2 |
3.130
|
-0.1000
|
-1.530
|
-0.7800
|
-1.530
|
3.930
|
1.380
|
-2.230
|
3.610
|
3.120
|
2.995
|
3.314
|
3.056
|
3.412
|
3.618
|
Dividend per Share
2 |
1.150
|
1.200
|
1.200
|
1.200
|
1.200
|
1.250
|
1.250
|
1.250
|
1.250
|
1.300
|
1.300
|
1.300
|
1.300
|
1.333
|
1.333
|
Announcement Date
|
2/3/22
|
5/3/22
|
8/2/22
|
11/1/22
|
2/7/23
|
5/2/23
|
8/1/23
|
11/1/23
|
2/6/24
|
4/30/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
13,953
|
13,840
|
14,531
|
11,904
|
8,983
|
11,371
|
11,371
|
11,446
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
9,812
|
-
|
-
|
3,000
|
-
|
-
|
ROE (net income / shareholders' equity)
|
12.1%
|
6.3%
|
8.93%
|
9.2%
|
12.2%
|
13.9%
|
13.5%
|
13.1%
|
ROA (Net income/ Total Assets)
|
0.57%
|
0.45%
|
0.61%
|
0.44%
|
0.61%
|
0.9%
|
0.9%
|
0.9%
|
Assets
1 |
739,445
|
-83,669
|
1,256,752
|
-325,782
|
409,278
|
504,218
|
545,007
|
607,819
|
Book Value Per Share
2 |
156.0
|
168.0
|
161.0
|
43.80
|
76.80
|
81.60
|
89.00
|
99.10
|
Cash Flow per Share
|
-
|
21.10
|
25.20
|
13.80
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/4/20
|
2/4/21
|
2/3/22
|
2/7/23
|
2/6/24
|
-
|
-
|
-
|
Last Close Price
116.7
USD Average target price
113.3
USD Spread / Average Target -2.88% Consensus |
1st Jan change
|
Capi.
|
---|
| +12.52% | 41.9B | | +13.06% | 78.69B | | +8.36% | 50.96B | | +2.82% | 48.2B | | +14.75% | 43.97B | | +5.98% | 30.84B | | -2.46% | 29.08B | | -12.22% | 26.6B | | +11.26% | 23.04B | | +20.42% | 21.32B |
Other Life & Health Insurance
|